Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications. - Test2 - elhamkhani - TriplyDB

Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

http://www.wikidata.org/entity/Q37947952

about

Polymeric Nanoparticles to Combat Squamous Cell Carcinomas in Patients with Dystrophic Epidermolysis Bullosa.Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.The nanomedicine revolution: part 1: emerging concepts.The nanomedicine revolution: part 3: regulatory and safety challenges.Design of siRNA Therapeutics from the Molecular Scale Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy.Visualization of custom-tailored iron oxide nanoparticles chemistry, uptake, and toxicity.A multi-scale molecular dynamics study of the assembly of micron-size supraparticles from 30 nm alkyl-coated nanoparticles.The nanomedicine revolution: part 2: current and future clinical applications.The effect of hyperbranched poly(acrylic acid)s on the morphology and size of precipitated nanoscale (fluor)hydroxyapatite

P2860

Q34678948-9DE4993D-1CB7-4D48-8E44-649D5719374C Q35625854-61063D91-E3AA-4D53-A166-16AFF67B594F Q36292618-3F75ACFC-D63D-424B-BA45-20495F909122 Q36401768-5301670A-7971-4483-8CA2-F94E60F537E4 Q37111734-6E856B64-5E47-41E9-992A-B21897A4A432 Q38094012-0B21E8BA-7790-4C1F-B17F-D79E5AE2B8D3 Q39258640-896ED84D-0517-4757-8FFB-78FB709CDB99 Q39434199-7C9BAE80-331D-4E9A-AF5D-421B5B25F18A Q39527453-82D0B9A2-EB40-4C3D-BD7E-AB7C0B267992 Q57306022-02F483B9-93EB-4063-84A8-DFFCA4889B14

P2860

Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

http://www.wikidata.org/entity/Q37947952

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Nanoparticle-based drug delive ...... d cardiovascular applications.

@en

Nanoparticle-based drug delive ...... d cardiovascular applications.

@nl

type

label

Nanoparticle-based drug delive ...... d cardiovascular applications.

@en

Nanoparticle-based drug delive ...... d cardiovascular applications.

@nl

prefLabel

Nanoparticle-based drug delive ...... d cardiovascular applications.

@en

Nanoparticle-based drug delive ...... d cardiovascular applications.

@nl

P1433

Q37947952-723DCC7D-FF29-4B6D-82A0-A8FC14B148A9

P1476

Q37947952-C8DF5C7E-79AB-4F35-8288-8E8CA042C3B8

P2093

Q37947952-14937F8C-50B5-4BFB-8457-2E60F533838D

Q37947952-1A6FC063-A53A-4198-AB6A-748DC230B3D1

Q37947952-45CD5F6C-DA1D-4A56-A9F1-6C8CDE2C876D

Q37947952-A42DD282-0162-443F-8F75-CDAB5DD6F90A

Q37947952-B004F5B6-F133-4B47-8845-903021FEC50E

Q37947952-B200FAB7-A29D-4510-AAA7-51ED45D09C5B

Q37947952-B57CF896-7F9E-4F97-98B6-9A84BB4EEA95

Q37947952-C5617EBF-8C40-4259-9F7B-88B960578EE0

Q37947952-FB6C66FC-722E-4FF5-950A-0FD7A6662737

P2860

Q37947952-0289A195-1B3F-40D3-8B54-C17D6E19074C

Q37947952-03BC9BA7-8058-4E88-B60A-A30A57ECE9C2

Q37947952-0546F51E-8DFC-4622-B936-4244FF14C882

Q37947952-06690DF2-451E-4DD3-9593-0A1EB9C705DE

Q37947952-0F1AD21F-17C4-4674-8833-B9353E4B8115

Q37947952-139297F9-2D6F-4746-A861-23150A0FCA29

Q37947952-13E6DD8C-2BD3-4182-A220-C799BEA24032

Q37947952-14BFF6F9-B1FB-4B9B-BBFB-28C7EF924919

Q37947952-15C692D0-8EE8-4F20-9563-481F119ABB14

Q37947952-15D0D2A1-9F74-4531-A38A-BC67E606FB90

P2888

Q37947952-FECB10B5-29F3-4C06-8D74-FF9CFDB543A6

P304

Q37947952-7216F614-42F7-4BF4-AB52-E035FF264A7A

P31

Q37947952-9D6E449F-8438-486F-A3D0-C64127C401B7

P356

Q37947952-2BE65DB6-62C1-44FD-9A9E-61D824B3D568

P433

Q37947952-D3E59F57-5F4E-49D5-BBF5-A5BD6C9CCC2A

P478

Q37947952-E62D7CF3-909F-42EF-A6AF-92188F3C8E2F

P50

Q37947952-069CC91E-81B8-4010-A8F0-86F050F3F07A

Q37947952-0C425484-00E1-4AB7-BCC3-498E0B70324C

Q37947952-48690DA3-9672-44C2-BA2F-28BBC3455F3B

Q37947952-9D82FE48-E970-4EC5-AE4D-01817E122E96

Q37947952-9DEDC6E0-64C8-4D7D-B0ED-96E375696BD9

Q37947952-BB9485C0-199A-4E44-A18F-A5FD3B0D3691

Q37947952-EAEBAF53-91C7-4A8A-B70D-915F2CF7780B

P577

Q37947952-43F404F1-2A87-412B-BE9F-C378505F7DDF

P698

Q37947952-4436A528-1433-4423-AFB4-F1AECC8DECDD

P921

Q37947952-7B29B23D-1A3D-48B4-933E-B0762A53ACED

Q37947952-BB03F5E5-B2A5-49B0-93CF-763C58DEE89C

P356

S00018-011-0856-6

P1433

Cellular and Molecular Life Sciences

P1476

Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications

@en

P2093

Anna McCarthy

http://www.w3.org/2001/XMLSchema#string

Brian D Maccraith

http://www.w3.org/2001/XMLSchema#string

Chris Keely

http://www.w3.org/2001/XMLSchema#string

Conor Duffy

http://www.w3.org/2001/XMLSchema#string

Conor S Burke

http://www.w3.org/2001/XMLSchema#string

Enda Keehan

http://www.w3.org/2001/XMLSchema#string

Maya Dyson

http://www.w3.org/2001/XMLSchema#string

Michael Howe

http://www.w3.org/2001/XMLSchema#string

Michelle T Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

pH-Responsive copolymer assemblies for controlled release of doxorubicin

One hundred years of lung cancer

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent.

Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging.

Solvent-free atom transfer radical polymerization for the preparation of poly(poly(ethyleneglycol) monomethacrylate)-grafted Fe3O4 nanoparticles: synthesis, characterization and cellular uptake.

Effects of different application parameters on penetration characteristics and arterial vessel wall integrity after local nanoparticle delivery using a porous balloon catheter.

In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.

P2888

s00018-011-0856-6

P304

389-404

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00018-011-0856-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Damien Thompson

Ronan MacLoughlin

P577

2011-10-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22015612

http://www.w3.org/2001/XMLSchema#string

P921